DNA Nanostructures‐Based In Situ Cancer Vaccines: Mechanisms and Applications
Small Methods · 2025
DOI: 10.1002/smtd.202401501 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, 2025. Verfasst von Bingyu Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, 410083, P. R. Chi…. Hauptthemen laut MEDLINE: Cancer Vaccines, Nanostructures, Neoplasms, DNA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 198 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation for Distinguished Young Scholars, Innovation-Driven Project of Central South University.
Abstract (Originalsprache)
Current tumor vaccines suffer from inadequate immune responsive due to the insufficient release of tumor antigens, low tumor infiltration, and immunosuppressive microenvironment. DNA nanostructures with their ability to precisely engineer, controlled release, biocompatibility, and the capability to augment the immunogenicity of tumor microenvironment, have gained significant attention for their potential to revolutionize vaccine designing. This review summarizes various applications of DNA nanostructures in the construction of in situ cancer vaccines, which can generate tumor‐associated antigens directly from damaged tumors for cancer immune‐stimulation. The mechanisms and components of cancer vaccines are listed, the specific strategies for constructing in situ vaccines using DNA nanostructures are explored and their underlying mechanisms of action are elucidated. The immunogenic cell death (ICD) induced by chemotherapeutic agents, photothermal therapy (PTT), photodynamic therapy (PDT), and radiation therapy (RT) and the related cancer vaccines building strategies are systematically summarized. The applications of different DNA nanostructures in various cancer immunotherapy are elaborated, which exerts precise, long‐lasting, and robust immune responses. The current challenges and future prospectives are proposed. This review provides a holistic understanding of the evolving role of DNA nanostructures for in situ vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, 410083, P. R. China.
- Department of Pharmaceutics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, P. R. China.
ORCID-Profile: Zhenbao Liu
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation for Distinguished Young Scholars
- Innovation-Driven Project of Central South University
- Hunan Provincial High-Level Health Talents
- Joint Fund of the Hunan Provincial Natural Science Foundation and the Hunan Medical Products Administration
- Hunan Provincial Innovation Foundation for Postgraduate
Zitieren
APA
Lin, B., Liu, Y., Chen, Q., Li, M., Xu, L., Chen, Q., Tan, Y., & Liu, Z. (2025). DNA Nanostructures‐Based In Situ Cancer Vaccines: Mechanisms and Applications. Small Methods. https://doi.org/10.1002/smtd.202401501
Vancouver
Lin B, Liu Y, Chen Q, Li M, Xu L, Chen Q, et al. DNA Nanostructures‐Based In Situ Cancer Vaccines: Mechanisms and Applications. Small Methods. 2025. doi:10.1002/smtd.202401501
BibTeX
@article{Lin2025,
author = {Lin, Bingyu and Liu, Yanfei and Chen, Qiwen and Li, Mingfeng and Xu, Lishang and Chen, Qianqian and Tan, Yifu and Liu, Zhenbao},
title = {DNA Nanostructures‐Based In Situ Cancer Vaccines: Mechanisms and Applications},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202401501}
}
EUVIMED